4/A: Bio-Key International CEO Michael DePasquale Amends SEC Filing to Correct Share Holdings

Sentiment:

SEC Filing Amendment


Michael DePasquale, CEO of Bio-Key International, files an amendment to a previous SEC Form 4 to update the total shares and excluded holdings.

Summary

  • Michael DePasquale, the CEO of Bio-Key International, filed an amended Form 4/A with the SEC.
  • The amendment updates the total shares and excluded holdings from the original Form 4 filed on August 2, 2024.
  • The transaction date for the reported activity is July 31, 2024.
  • DePasquale acquired 24,000 shares of common stock at $0.
  • Following the reported transaction, DePasquale beneficially owns 39,380 shares.
  • The holdings do not include options to purchase 464 shares and warrants to purchase 9167 shares.
  • The 24,000 shares are restricted stock granted under the Issuer's 2023 Stock Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to continued employment.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it primarily involves correcting a previous filing. The acquisition of shares could be seen as slightly positive, but the amendment itself doesn't strongly indicate positive or negative sentiment.

Positives

  • The CEO's acquisition of 24,000 shares, even at $0, could be interpreted as a sign of confidence in the company's future.

Risks

  • The amendment suggests a potential oversight in the initial filing, which could raise questions about the accuracy of other disclosures.

Industry Context

SEC filings are a routine part of corporate governance and provide transparency into the transactions of company insiders. Amendments are not uncommon and can be due to various reasons, including correcting errors or providing additional information.

Stakeholder Impact

  • The correction of the filing ensures accurate information is available to shareholders.

Key Dates

DateDescription
07/31/2024Date of the transaction where shares were acquired.
08/02/2024Date of the original Form 4 filing and the amended Form 4/A filing.

Keywords

SEC Filing, Form 4/A, Beneficial Ownership, Bio-Key International, Michael DePasquale, Stock Incentive Plan, Restricted Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.